Who To Contact

Baptist MD Anderson
Cancer Center
1301 Palm Avenue
Jacksonville, FL 32207

Poonam K. Neki, MBBS,DA, CCRP
Research Director
Baptist MD Anderson Clinical Trials
904.202.7468
poonam.neki@bmcjax.com

Clinical Trial ID: NCT05079230

A Phase III, Randomized Double-Blind, Placebo-controlled Study Evaluating the Safety and Efficacy of Magrolimab versus Placebo in Combination with Venetoclax and Azacitidine in Newly Diagnosed, Previously untreated Patients with Acute Myeloid Leukemia Who are ineligible for Intensive Chemotherapy

Status

Open

Conditions

Other

Phases

III

Age Group

Adult

Main Investiagtor

Norkin, Maxim

Practice

Heme

Scope

National

Participating Institutions

Baptist MD Anderson Cancer Center

Nct ID Number

NCT05079230

Secondary Trial ID Number

GS-US-590-6154

Keywords

Treatment